MEXICO CITY, Feb. 09, 2016 -- Empresas ICA, S.AB. de C.V. (BMV:ICA) (NYSE:ICA), the largest infrastructure and construction company in Mexico, confirmed today that its subsidiary COVIMSA has signed an agreement with CKD Fomento a la Energía e Infraestructura de México (EXI), through the EXICK Trust, for a Ps. 750 million convertible loan to provide the resources required for the completion of the Palmillas-Apaseo El Grande tollroad in the states of Queretaro and Guanajuato.
Autovía Queretaro, S.A. de C.V., a subsidiary of COVIMSA, holds the 30-year concession to construction, operate, exploit, preserve, and maintain the highway.
The Palmillas–Apaseo El Grande tollroad is one of the most important construction projects in Mexico. The 4-lane, 86 km, high-specification tollroad in Queretaro and Guanajuato is expected to reduce traffic congestion resulting from the sustained economic growth of the region.
This agreement ensures all the resources that are required to finalize the construction and putting into service of the highway. ICA expects that the construction phase will be completed in September 2016, and the highway will join ICA’s existing portfolio of five operating highways.
This press release contains projections or other forward-looking statements related to ICA that reflect ICA’s current expectations or beliefs concerning future events. Such forward-looking statements are subject to various risks and uncertainties and may differ materially from actual results or events due to important factors such as changes in general economic, business or political or other conditions in Mexico, Latin America or elsewhere, changes in capital markets in general that may affect policies or attitudes towards lending to Mexico or Mexican companies, changes in tax and other laws affecting ICA’s businesses, increased costs, unanticipated increases in financing and other costs or the inability to obtain additional debt or equity financing on attractive terms and other factors set forth in ICA’s most recent filing on Form 20-F and in any filing or submission ICA has made with the SEC subsequent to its most recent filing on Form 20-F. All forward-looking statements are based on information available to ICA on the date hereof, and ICA assumes no obligation to update such statements.
Empresas ICA, S.A.B. de C.V. is Mexico's largest infrastructure company. ICA carries out large-scale civil and industrial construction projects and operates a portfolio of long-term assets, including airports, toll roads, water systems, and real estate. Founded in 1947, lCA is listed on the Mexican and New York Stock exchanges. For more information, visit ir.ica.mx.
For more information, please contact: Gabriela Orozco [email protected] [email protected] +(5255) 5272 9991 x 3012 Pablo Garcia Chief Financial Officer [email protected] In the US: Daniel Wilson, Zemi Communications +(1212) 689 9560 [email protected]


Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



